KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Up 19.8% in January

KindlyMD, Inc. (NASDAQ:NAKA) saw a significant growth in short interest in January. As of January 30th, there was short interest totaling 21,409,965 shares, a growth of 19.8% from the January 15th total of 17,871,354 shares. Approximately 5.1% of the company’s stock are short sold. Based on an average trading volume of 4,733,708 shares, the short-interest ratio is presently 4.5 days. Based on an average trading volume of 4,733,708 shares, the short-interest ratio is presently 4.5 days. Approximately 5.1% of the company’s stock are short sold.

KindlyMD Trading Down 2.6%

NASDAQ:NAKA traded down $0.01 during mid-day trading on Wednesday, hitting $0.27. The company’s stock had a trading volume of 2,652,231 shares, compared to its average volume of 5,849,224. The company has a market capitalization of $116.56 million, a price-to-earnings ratio of -0.24 and a beta of 31.46. KindlyMD has a fifty-two week low of $0.25 and a fifty-two week high of $34.77. The stock has a fifty day moving average of $0.38 and a 200-day moving average of $2.20.

Institutional Investors Weigh In On KindlyMD

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its stake in shares of KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after buying an additional 8,386 shares during the period. Osaic Holdings Inc. acquired a new stake in KindlyMD in the second quarter worth about $215,000. Vontobel Holding Ltd. acquired a new position in KindlyMD during the 3rd quarter valued at about $335,000. Dynamic Technology Lab Private Ltd bought a new position in shares of KindlyMD in the 3rd quarter valued at about $369,000. Finally, Tower Research Capital LLC TRC grew its position in shares of KindlyMD by 1,638.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock worth $827,000 after buying an additional 31,245 shares during the period.

Analyst Ratings Changes

Several research firms recently weighed in on NAKA. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of KindlyMD in a research report on Monday, December 29th. B. Riley Financial decreased their price objective on shares of KindlyMD from $2.00 to $1.00 and set a “buy” rating for the company in a report on Thursday, November 20th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $4.50.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.